Clinical validation of Smart Flux hemodialysis filter made by Medica s.p.a company (Italy) with hollow fiber M-PES model, belongs to Mahan Med Meymeh Kish Company, in hemodialysis patients.

Mahan Med Meymeh Kish0 个研究点目标入组 40 人开始时间: 待定最近更新: 2020年5月18日

适应症

试验速览

暂无简介。

•To be on hemodialysis more than 3 months
•Age more than 20 year and less than 75 year.
•Have stable clinical and laboratory condition, (Corrected Ca>8mg%, K=5.5 Hct>20%).
•Scheduled regular 3 times weekly hemodialysis program.
•Have stable vascular access.
•Have stable blood pressure.
•Have stable hemodynamic and cardiovascular condition, (for example no heart attack or cerebrovascular events in last three months).
•Have no acute infection or malignant tumors
•Have no severe anemia ( hematocrit more than 20%)
•Patient give informed consent to participate in this clinical trial

•Patient has uncontrolled high or low blood pressure (systolic BP less than 90 mmHg or more than 180 mmHg at the start of hemodialysis.
•For any reason the patient needs for blood transfusion.
•For any reason the patient needs hospitalization.

发起方

Mahan Med Meymeh Kish